Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Executes Letter of Intent to Acquire Consolidated Craft Brands

January 11, 2021


BURLINGTON, Ontario January 11, 2021 – Rapid Dose Therapeutics Corp. “RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce that it has entered into a binding Letter of Intent “LOI”)...

Rapid Dose Therapeutics Delivers Shipments of Oral Strips to Thrive Cannabis, in Stores Now

December 21, 2020


BURLINGTON, Ontario December 21, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, has worked diligently with its customer, Thrive Cannabis Inc. (“Thrive”), this past year preparing to...

Rapid Dose Therapeutics Closes First Tranche of Non-Brokered Private Placement

December 15, 2020


BURLINGTON, Ontario – December 15, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce the closing of the first tranche of a Non-Brokered Private...

Rapid Dose Therapeutics Signs Definitive Agreement to Enable Commercial Production of Ultrapure THC™ Distillate Using RDT’s Novel CBD to THC Conversion Technology

November 25, 2020


BURLINGTON, Ontario – November 25, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it signed a definitive agreement with ESJ Enterprises, LLC. RDT...

Rapid Dose Therapeutics Corp. Announces Revocation of Cease Trade Order

November 19, 2020


BURLINGTON, Ontario – November 19, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has, as of November 18, 2020, received a Revocation...

Rapid Dose Therapeutics Amends Agreement With Aphria to Produce in Burlington, Ontario Facility

September 29, 2020


BURLINGTON, Ontario – September 29, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has amended the agreement with Aphria Inc. (TSE:APHA, Nasdaq:APHA)...

Rapid Dose Therapeutics Announces a New Board Member

August 13, 2020


Burlington, Ontario – August 13, 2020 – Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company“) announces the appointment of Mr. Peter Thilo Hasler to the board of directors. Mark Upsdell, CEO of RDT said...

Rapid Dose Therapeutics Announces Credit Facility Financing

August 11, 2020


Burlington, Ontario – August 11, 2020 – Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company“) announces that the Company, in conjunction with Leede Jones Gable,  has received an initial advance from a strategic industry...

Rapid Dose Therapeutics Delay Announces Delay in Annual Filings Under Covid-19 Duress

June 26, 2020


Burlington, Ontario – June 26, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that due to circumstances created by the COVID-19 pandemic, the Ontario Securities Commission and other members of the Canadian Securities Administrators granted “Issuers” in the Canadian securities...

Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process

June 19, 2020


BURLINGTON, Ontario – June 19, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has filed a non-provisional patent with the USPTO for...

1 2 3 4 5 6